Table 3 Time investment by participating non-genetic healthcare professionals in the questionnaire.

From: Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer

 

Total, n (%)

How much time did you spend discussing genetic testing?a

  0–10 min

50 (82%)

  10–20 min

10 (16%)

  >20 min

1 (2%)

Is the amount of time that you spent discussing genetic testing what you expected? It was:a

  Better or much better than expected

40 (66%)

  Neither better nor worse than expected

18 (30%)

  Worse or much worse than expected

3 (5%)

How much time did you spend ordering genetic testing?b

  0–10 min

39 (85%)

  10–20 min

5 (11%)

  >20 min

2 (4%)

Is the amount of time that you spent ordering genetic testing what you expected? It was:c

  Better or much better than expected

28 (58%)

  Neither better nor worse than expected

13 (27%)

  Worse or much worse than expected

7 (15%)

Is the total time investment for discussing and/or ordering genetic testing feasible?d

  Yes

52 (84%)

  No

6 (10%)

  I don’t know

4 (6%)

  1. an = 61 (8 non-genetic healthcare professionals (ngHCPs) answered ‘not applicable’/answer was missing).
  2. bn = 46 (23 ngHCPs answered ‘not applicable’/answer was missing).
  3. cn = 48 (21 ngHCPs answered ‘not applicable’/answer was missing).
  4. dn = 62 (7 ngHCPs answered ‘not applicable’/answer was missing).